CK Life Sciences Int'l., (Holdings) Inc.

HK$0.53As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0775Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (1.51%)
Div yield —
ROE (2.23%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (41.67%)
Mkt cap HK$5.046B
ROIC 0.10%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.654
24.65%
98.53%
Buy 11|4|1|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
4.07%
12.62%
16.39%
22.05%
Revenue$M
603.8
637.3
661.6
667.8
0.47%
7.16%
13.21%
14.07%
Peers (US$643.6M)
Cap (US$)
PE
772.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.440
(1.134)
(0.928)
EBIT/Intx
0.733
1.976
1.968
Own earn%
8.67
104.34
103.29
Sh yield%
30.80
1.55
3.43
Owners
Insiders/Inst%
7.85
88.12
Short interest%
2.79
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
29–37
$1 testx
0.0
Incr. ROIC%
12